Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schütte J[au]:

Search results

Items: 1 to 50 of 231

1.

Maternal mortality due to cardiovascular disease in the Netherlands: a 21-year experience.

Lameijer H, Schutte JM, Schuitemaker NWE, van Roosmalen JJM, Pieper PG; Dutch Maternal Mortality and Morbidity Committee.

Neth Heart J. 2020 Jan;28(1):27-36. doi: 10.1007/s12471-019-01340-w.

2.

Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.

Verpalen IM, Anneveldt KJ, Nijholt IM, Schutte JM, Dijkstra JR, Franx A, Bartels LW, Moonen CTW, Edens MA, Boomsma MF.

Eur J Radiol. 2019 Nov;120:108700. doi: 10.1016/j.ejrad.2019.108700. Epub 2019 Oct 15.

PMID:
31634683
3.

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies.

Schütte J, Reusch J, Khandanpour C, Eisfeld C.

Front Oncol. 2019 Aug 28;9:839. doi: 10.3389/fonc.2019.00839. eCollection 2019. Review.

4.

Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.

de Sonnaville CMW, Hukkelhoven CW, Vlemmix F, Groen H, Schutte JM, Mol BW, van Pampus MG.

Ultrasound Obstet Gynecol. 2020 Jan;55(1):58-67. doi: 10.1002/uog.20417. Epub 2019 Sep 4.

PMID:
31486156
5.

Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.

Barth J, Abou-El-Ardat K, Dalic D, Kurrle N, Maier AM, Mohr S, Schütte J, Vassen L, Greve G, Schulz-Fincke J, Schmitt M, Tosic M, Metzger E, Bug G, Khandanpour C, Wagner SA, Lübbert M, Jung M, Serve H, Schüle R, Berg T.

Leukemia. 2019 Jun;33(6):1541. doi: 10.1038/s41375-019-0415-y.

PMID:
30837671
6.

LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.

Barth J, Abou-El-Ardat K, Dalic D, Kurrle N, Maier AM, Mohr S, Schütte J, Vassen L, Greve G, Schulz-Fincke J, Schmitt M, Tosic M, Metzger E, Bug G, Khandanpour C, Wagner SA, Lübbert M, Jung M, Serve H, Schüle R, Berg T.

Leukemia. 2019 Jun;33(6):1411-1426. doi: 10.1038/s41375-018-0375-7. Epub 2019 Jan 24. Erratum in: Leukemia. 2019 Mar 5;:.

PMID:
30679800
7.

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.

Hüttmann A, Rekowski J, Müller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, La Rosée P, Freesmeyer M, Höffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Schütte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, Pöpperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, Höhler T, Steiniger H, Nückel H, Südhoff T, Römer W, Brinkmann M, Ose C, Alashkar F, Schmitz C, Dürig J, Hoelzer D, Jöckel KH, Klapper W, Dührsen U.

Ann Hematol. 2019 Apr;98(4):897-907. doi: 10.1007/s00277-018-3578-0. Epub 2019 Jan 4.

PMID:
30610279
8.

Maternal mortality after cesarean section in the Netherlands.

Kallianidis AF, Schutte JM, van Roosmalen J, van den Akker T; Maternal Mortality and Severe Morbidity Audit Committee of the Netherlands Society of Obstetrics and Gynecology.

Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:148-152. doi: 10.1016/j.ejogrb.2018.08.586. Epub 2018 Aug 30.

PMID:
30195138
9.

[Isolated fallopian tubal torsion; rare or overlooked?]

Verpalen IM, de Boer J, van den Hoed RD, Schutte JM, Teklenburg G, Vossenkaul R.

Ned Tijdschr Geneeskd. 2018 Jul 13;162. pii: D2670. Dutch.

PMID:
30040317
10.

GFI1 is required for RUNX1/ETO positive acute myeloid leukemia.

Marneth AE, Botezatu L, Hönes JM, Israël JCL, Schütte J, Vassen L, Lams RF, Bergevoet SM, Groothuis L, Mandoli A, Martens JHA, Huls G, Jansen JH, Dührsen U, Berg T, Möröy T, Wichmann C, Lo MC, Zhang DE, van der Reijden BA, Khandanpour C.

Haematologica. 2018 Sep;103(9):e395-e399. doi: 10.3324/haematol.2017.180844. Epub 2018 Apr 19. No abstract available.

11.

Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndrome.

Thivakaran A, Botezatu L, Hönes JM, Schütte J, Vassen L, Al-Matary YS, Patnana P, Zeller A, Heuser M, Thol F, Gabdoulline R, Olberding N, Frank D, Suslo M, Köster R, Lennartz K, Görgens A, Giebel B, Opalka B, Dührsen U, Khandanpour C.

Haematologica. 2018 Apr;103(4):614-625. doi: 10.3324/haematol.2017.167288. Epub 2018 Jan 11.

12.

Cancer related maternal mortality and delay in diagnosis and treatment: a case series on 26 cases.

de Haan J, Lok CAR, Schutte JS, van Zuylen L, de Groot CJM.

BMC Pregnancy Childbirth. 2018 Jan 5;18(1):10. doi: 10.1186/s12884-017-1639-3.

13.

[Trisomy 18: how lethal is 'lethal'?]

Brouwer MA, Maeckelberghe ELM, van der Hoeven MAFBM, Schutte J, Wee HL, Willekes C, Verhagen AAE.

Ned Tijdschr Geneeskd. 2017;161:D1716. Dutch.

PMID:
29171368
14.

Enforced GFI1 expression impedes human and murine leukemic cell growth.

Hönes JM, Thivakaran A, Botezatu L, Patnana P, Castro SVDC, Al-Matary YS, Schütte J, Fischer KBI, Vassen L, Görgens A, Dührsen U, Giebel B, Khandanpour C.

Sci Rep. 2017 Nov 16;7(1):15720. doi: 10.1038/s41598-017-15866-9.

15.

Maternal mortality: direct or indirect has become irrelevant.

van den Akker T, Nair M, Goedhart M, Schutte J, Schaap T, Knight M; Netherlands Audit Committee Maternal Mortality Morbidity; UK Confidential Enquiry into Maternal Deaths.

Lancet Glob Health. 2017 Dec;5(12):e1181-e1182. doi: 10.1016/S2214-109X(17)30426-6. No abstract available.

16.

Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.

Lemmers M, Verschoor MAC, Overwater K, Bossuyt PM, Hendriks D, Hemelaar M, Schutte JM, Adriaanse AH, Ankum WM, Huirne JAF, Mol BWJ.

Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:78-82. doi: 10.1016/j.ejogrb.2017.01.055. Epub 2017 Jan 30.

PMID:
28199872
17.

Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.

Al-Matary YS, Botezatu L, Opalka B, Hönes JM, Lams RF, Thivakaran A, Schütte J, Köster R, Lennartz K, Schroeder T, Haas R, Dührsen U, Khandanpour C.

Haematologica. 2016 Oct;101(10):1216-1227. Epub 2016 Jul 7.

18.

Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).

Schmitt T, Mayer-Steinacker R, Mayer F, Grünwald V, Schütte J, Hartmann JT, Kasper B, Hüsing J, Hajda J, Ottawa G, Mechtersheimer G, Mikus G, Burhenne J, Lehmann L, Heilig CE, Ho AD, Egerer G.

Eur J Cancer. 2016 Sep;64:74-82. doi: 10.1016/j.ejca.2016.05.018. Epub 2016 Jun 28.

PMID:
27367154
19.

Procalcitonin-guided antibiotic treatment in critically ill patients.

Hohn A, Heising B, Schütte JK, Schroeder O, Schröder S.

Langenbecks Arch Surg. 2017 Feb;402(1):1-13. doi: 10.1007/s00423-016-1458-4. Epub 2016 Jun 10. Review.

PMID:
27283067
20.

Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.

Botezatu L, Michel LC, Helness A, Vadnais C, Makishima H, Hönes JM, Robert F, Vassen L, Thivakaran A, Al-Matary Y, Lams RF, Schütte J, Giebel B, Görgens A, Heuser M, Medyouf H, Maciejewski J, Dührsen U, Möröy T, Khandanpour C.

Exp Hematol. 2016 Aug;44(8):713-726.e14. doi: 10.1016/j.exphem.2016.05.004. Epub 2016 May 20.

21.

Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

Eriksson M, Reichardt P, Sundby Hall K, Schütte J, Cameron S, Hohenberger P, Bauer S, Leinonen M, Reichardt A, Rejmyr Davis M, Alvegård T, Joensuu H.

Eur J Cancer. 2016 May;59:128-133. doi: 10.1016/j.ejca.2016.02.021. Epub 2016 Mar 28.

PMID:
27033260
22.

An experimentally validated network of nine haematopoietic transcription factors reveals mechanisms of cell state stability.

Schütte J, Wang H, Antoniou S, Jarratt A, Wilson NK, Riepsaame J, Calero-Nieto FJ, Moignard V, Basilico S, Kinston SJ, Hannah RL, Chan MC, Nürnberg ST, Ouwehand WH, Bonzanni N, de Bruijn MF, Göttgens B.

Elife. 2016 Feb 22;5:e11469. doi: 10.7554/eLife.11469.

23.

GFI1 as a novel prognostic and therapeutic factor for AML/MDS.

Hönes JM, Botezatu L, Helness A, Vadnais C, Vassen L, Robert F, Hergenhan SM, Thivakaran A, Schütte J, Al-Matary YS, Lams RF, Fraszscak J, Makishima H, Radivoyevitch T, Przychodzen B, da Conceição Castro SV, Görgens A, Giebel B, Klein-Hitpass L, Lennartz K, Heuser M, Thiede C, Ehninger G, Dührsen U, Maciejewski JP, Möröy T, Khandanpour C.

Leukemia. 2016 Jun;30(6):1237-45. doi: 10.1038/leu.2016.11. Epub 2016 Feb 5.

PMID:
26847026
24.

Integrated genome-scale analysis of the transcriptional regulatory landscape in a blood stem/progenitor cell model.

Wilson NK, Schoenfelder S, Hannah R, Sánchez Castillo M, Schütte J, Ladopoulos V, Mitchelmore J, Goode DK, Calero-Nieto FJ, Moignard V, Wilkinson AC, Jimenez-Madrid I, Kinston S, Spivakov M, Fraser P, Göttgens B.

Blood. 2016 Mar 31;127(13):e12-23. doi: 10.1182/blood-2015-10-677393. Epub 2016 Jan 25.

PMID:
26809507
25.

ConBind: motif-aware cross-species alignment for the identification of functional transcription factor binding sites.

Lelieveld SH, Schütte J, Dijkstra MJ, Bawono P, Kinston SJ, Göttgens B, Heringa J, Bonzanni N.

Nucleic Acids Res. 2016 May 5;44(8):e72. doi: 10.1093/nar/gkv1518. Epub 2015 Dec 31.

26.

Tissue microchimerism is increased during pregnancy: a human autopsy study.

Rijnink EC, Penning ME, Wolterbeek R, Wilhelmus S, Zandbergen M, van Duinen SG, Schutte J, Bruijn JA, Bajema IM.

Mol Hum Reprod. 2015 Nov;21(11):857-64. doi: 10.1093/molehr/gav047. Epub 2015 Aug 24.

PMID:
26307194
27.

Microfluidic chip system for the selection and enrichment of cell binding aptamers.

Stoll H, Kiessling H, Stelzle M, Wendel HP, Schütte J, Hagmeyer B, Avci-Adali M.

Biomicrofluidics. 2015 Jun 15;9(3):034111. doi: 10.1063/1.4922544. eCollection 2015 May.

28.

Classical Complement Pathway Activation in the Kidneys of Women With Preeclampsia.

Penning M, Chua JS, van Kooten C, Zandbergen M, Buurma A, Schutte J, Bruijn JA, Khankin EV, Bloemenkamp K, Karumanchi SA, Baelde H.

Hypertension. 2015 Jul;66(1):117-25. doi: 10.1161/HYPERTENSIONAHA.115.05484. Epub 2015 May 4.

29.

Regional differences in severe postpartum hemorrhage: a nationwide comparative study of 1.6 million deliveries.

Prick BW, Auf Altenstadt JF, Hukkelhoven CW, Bonsel GJ, Steegers EA, Mol BW, Schutte JM, Bloemenkamp KW, Duvekot JJ.

BMC Pregnancy Childbirth. 2015 Feb 21;15:43. doi: 10.1186/s12884-015-0473-8.

30.

Usability and reliability of a remotely administered adult autism assessment, the autism diagnostic observation schedule (ADOS) module 4.

Schutte JL, McCue MP, Parmanto B, McGonigle J, Handen B, Lewis A, Pulantara IW, Saptono A.

Telemed J E Health. 2015 Mar;21(3):176-84. doi: 10.1089/tmj.2014.0011. Epub 2015 Jan 8.

31.

Radioembolization in patients with progressive gastrointestinal stromal tumor liver metastases undergoing treatment with tyrosine kinase inhibitors.

Rathmann N, Diehl SJ, Dinter D, Schütte J, Pink D, Schoenberg SO, Hohenberger P.

J Vasc Interv Radiol. 2015 Feb;26(2):231-8. doi: 10.1016/j.jvir.2014.09.020. Epub 2014 Nov 26.

PMID:
25434477
32.

Constrained transcription factor spacing is prevalent and important for transcriptional control of mouse blood cells.

Ng FS, Schütte J, Ruau D, Diamanti E, Hannah R, Kinston SJ, Göttgens B.

Nucleic Acids Res. 2014 Dec 16;42(22):13513-24. doi: 10.1093/nar/gku1254. Epub 2014 Nov 26.

33.

Single-cell analyses of regulatory network perturbations using enhancer-targeting TALEs suggest novel roles for PU.1 during haematopoietic specification.

Wilkinson AC, Kawata VK, Schütte J, Gao X, Antoniou S, Baumann C, Woodhouse S, Hannah R, Tanaka Y, Swiers G, Moignard V, Fisher J, Hidetoshi S, Tijssen MR, de Bruijn MF, Liu P, Göttgens B.

Development. 2014 Oct;141(20):4018-30. doi: 10.1242/dev.115709. Epub 2014 Sep 24.

34.

Association of preeclampsia with podocyte turnover.

Penning ME, Bloemenkamp KW, van der Zon T, Zandbergen M, Schutte JM, Bruijn JA, Bajema IM, Baelde HJ.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1377-85. doi: 10.2215/CJN.12811213. Epub 2014 Jul 17.

35.

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.

Joensuu H, Eriksson M, Hall KS, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman KV, Leinonen M, DeMatteo RP, Reichardt P.

Cancer. 2014 Aug 1;120(15):2325-33. doi: 10.1002/cncr.28669. Epub 2014 Apr 15.

36.

Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.

Goldberg L, Tijssen MR, Birger Y, Hannah RL, Kinston SJ, Schütte J, Beck D, Knezevic K, Schiby G, Jacob-Hirsch J, Biran A, Kloog Y, Marcucci G, Bloomfield CD, Aplan PD, Pimanda JE, Göttgens B, Izraeli S.

Blood. 2013 Oct 10;122(15):2694-703. doi: 10.1182/blood-2013-01-477133. Epub 2013 Aug 23.

37.

Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes.

Beck D, Thoms JA, Perera D, Schütte J, Unnikrishnan A, Knezevic K, Kinston SJ, Wilson NK, O'Brien TA, Göttgens B, Wong JW, Pimanda JE.

Blood. 2013 Oct 3;122(14):e12-22. doi: 10.1182/blood-2013-03-490425. Epub 2013 Aug 23.

PMID:
23974199
38.

Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.

Buurma AJ, Penning ME, Prins F, Schutte JM, Bruijn JA, Wilhelmus S, Rajakumar A, Bloemenkamp KW, Karumanchi SA, Baelde HJ.

Hypertension. 2013 Sep;62(3):608-13. doi: 10.1161/HYPERTENSIONAHA.113.01505. Epub 2013 Jul 1.

PMID:
23817495
39.

Hard-wired heterogeneity in blood stem cells revealed using a dynamic regulatory network model.

Bonzanni N, Garg A, Feenstra KA, Schütte J, Kinston S, Miranda-Saavedra D, Heringa J, Xenarios I, Göttgens B.

Bioinformatics. 2013 Jul 1;29(13):i80-8. doi: 10.1093/bioinformatics/btt243.

40.

PP034. Renal histology in preeclampsia: A special role for the podocyte.

Penning M, Bloemenkamp K, Schutte J, Bruijn JA, Bajema I, Baelde H.

Pregnancy Hypertens. 2013 Apr;3(2):79. doi: 10.1016/j.preghy.2013.04.061. Epub 2013 Jun 6.

PMID:
26105891
41.

Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis.

Moignard V, Macaulay IC, Swiers G, Buettner F, Schütte J, Calero-Nieto FJ, Kinston S, Joshi A, Hannah R, Theis FJ, Jacobsen SE, de Bruijn MF, Göttgens B.

Nat Cell Biol. 2013 Apr;15(4):363-72. doi: 10.1038/ncb2709. Epub 2013 Mar 24. Erratum in: Nat Cell Biol. 2013 May;15(5):544.

42.

Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia.

Khandanpour C, Phelan JD, Vassen L, Schütte J, Chen R, Horman SR, Gaudreau MC, Krongold J, Zhu J, Paul WE, Dührsen U, Göttgens B, Grimes HL, Möröy T.

Cancer Cell. 2013 Feb 11;23(2):200-14. doi: 10.1016/j.ccr.2013.01.011.

43.

Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.

Oram SH, Thoms J, Sive JI, Calero-Nieto FJ, Kinston SJ, Schütte J, Knezevic K, Lock RB, Pimanda JE, Göttgens B.

Leukemia. 2013 Jun;27(6):1348-57. doi: 10.1038/leu.2013.2. Epub 2013 Jan 10.

44.

An integrated telehealth system for remote administration of an adult autism assessment.

Parmanto B, Pulantara IW, Schutte JL, Saptono A, McCue MP.

Telemed J E Health. 2013 Feb;19(2):88-94. doi: 10.1089/tmj.2012.0104. Epub 2012 Dec 11.

PMID:
23230821
45.

Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis.

Montemurro M, Gelderblom H, Bitz U, Schütte J, Blay JY, Joensuu H, Trent J, Bauer S, Rutkowski P, Duffaud F, Pink D.

Eur J Cancer. 2013 Mar;49(5):1027-31. doi: 10.1016/j.ejca.2012.10.009. Epub 2012 Nov 6.

PMID:
23140824
46.

3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia.

Schütte JK, Schäfer U, Becker S, Oldewurtel C, Starosse A, Singler P, Richard A, Wappler F, Gerbershagen MU.

Eur J Anaesthesiol. 2013 Jan;30(1):29-37. doi: 10.1097/EJA.0b013e32835a1127.

PMID:
23138574
47.

The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice.

Khandanpour C, Krongold J, Schütte J, Bouwman F, Vassen L, Gaudreau MC, Chen R, Calero-Nieto FJ, Diamanti E, Hannah R, Meyer SE, Grimes HL, van der Reijden BA, Jansen JH, Patel CV, Peeters JK, Löwenberg B, Dührsen U, Göttgens B, Möröy T.

Blood. 2012 Nov 8;120(19):4006-17. doi: 10.1182/blood-2011-02-334722. Epub 2012 Aug 28.

PMID:
22932805
48.

Fatal meningitis during pregnancy in the Netherlands: a nationwide confidential enquiry.

Schaap TP, Schutte JM, Zwart JJ, Schuitemaker NW, van Roosmalen J; Dutch Maternal Mortality Committee.

BJOG. 2012 Dec;119(13):1558-63. doi: 10.1111/j.1471-0528.2012.03443.x. Epub 2012 Aug 24.

49.

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer.

Schuler M, Awada A, Harter P, Canon JL, Possinger K, Schmidt M, De Grève J, Neven P, Dirix L, Jonat W, Beckmann MW, Schütte J, Fasching PA, Gottschalk N, Besse-Hammer T, Fleischer F, Wind S, Uttenreuther-Fischer M, Piccart M, Harbeck N.

Breast Cancer Res Treat. 2012 Aug;134(3):1149-59. doi: 10.1007/s10549-012-2126-1. Epub 2012 Jul 5.

50.

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.

Mross K, Dittrich C, Aulitzky WE, Strumberg D, Schutte J, Schmid RM, Hollerbach S, Merger M, Munzert G, Fleischer F, Scheulen ME.

Br J Cancer. 2012 Jul 10;107(2):280-6. doi: 10.1038/bjc.2012.257. Epub 2012 Jun 14.

Supplemental Content

Loading ...
Support Center